Premier Perspectives The blog for insider insights in clinical development Recent Posts By expertise area All expertise areas Medical DeviceRare DiseaseOncology & HematologyDiagnosticsDigital TherapeuticsMedTechPediatricsNeuroscienceAnalgesiaDermatologyOtherCOVID-19Cell & Gene TherapyWomen's HealthReal-World & Late PhaseLife at Premier By functional area All functional areas Development StrategyClinical Research: Phase 1 - Phase 4ConsultingData Management & BiostatisticsFunctional Service Provider (FSP)Global ComplianceMedical and Regulatory AffairsPatient and Stakeholder EngagementProject ManagementQualityReal-World Science and Late PhaseSafety/PharmacovigilanceStudy DesignStudy Start-UpOtherCOVID-19Product Development Global Compliance Strategic Planning for Compliance With the EU Medical Device Regulation By Nach Davé June 12, 2019 Consulting FAQ: How the EU Medical Devices Regulation Affects Existing Products By Nach Davé May 8, 2019 Medical and Regulatory Affairs The Evolution of Regulations for Digital Health Products By Nach Davé November 5, 2018 Consulting Sponsors and CROs get More Clarity on Precision, Targeted Therapy Trials By Nach Davé January 3, 2018 Consulting 5 Operational Considerations for Rare Disease Trials By Nach Davé December 27, 2017 Consulting Optimizing Regulatory Considerations for Orphan-Drug Development on a Global Scale By Nach Davé December 19, 2017 Previous 1 2 3 4 Next × ALSO OF INTERESTGene Therapy 101: From the 1960s to TodayKey Considerations When Designing a Phase 1...Nostalgia or Shell Shock? Assessing PTSD Is a...